gemcitabine has been researched along with Cholangiitis, Sclerosing in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SJ; Hwang, HW; Jeong, S; Lee, DH; Park, JS | 1 |
| Ajiki, T; Fukumoto, T; Ku, Y; Matsumoto, I; Matsumoto, T; Murakami, S; Okazaki, T; Shinozaki, K; Shinzeki, M; Yoshida, Y | 1 |
| Ajiki, T; Fukumoto, T; Kido, M; Ku, Y; Matsumoto, I; Murakami, S; Ohtsubo, I; Okazaki, T; Shinozaki, K; Shinzeki, M; Yoshida, Y | 1 |
3 other study(ies) available for gemcitabine and Cholangiitis, Sclerosing
| Article | Year |
|---|---|
Klatskin tumor diagnosed concurrently with IgG4 related sclerosing cholangitis: A case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Cisplatin; Common Bile Duct; Deoxycytidine; Diagnosis, Differential; Gemcitabine; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Jaundice; Klatskin Tumor; Male; Pruritus; Steroids; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
[Long-term survivor of unresectable bile duct cancer complicated with sclerosing cholangitis treated with chemotherapy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Deoxycytidine; Fatal Outcome; Female; Gemcitabine; Humans | 2014 |
[Long-term survival in 2 cases with unresectable hilar bile duct cancer and sclerosing cholangitis].
Topics: Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Cholangitis, Sclerosing; Deoxycytidine; Female; Gemcitabine; Humans; Male; Time Factors; Treatment Outcome | 2012 |